Correction: Cost of Anti-CD38 Monoclonal Antibodies in Combination With Bortezomib, Lenalidomide and Dexamethasone for the Frontline Treatment of Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma in the US

[This corrects the article DOI: 10.36469/001c.141714.]. Keywords: cost analysis; daratumumab; isatuximab; multiple myeloma; whol... ...